Atara Biotherapeutics, Inc. (ATRA) vs ImmuCell Corporation (ICCC)
Atara Biotherapeutics, Inc. and ImmuCell Corporation are both Biotechnology companies. Atara Biotherapeutics, Inc. and ImmuCell Corporation are of similar size ($90.6M and $85.7M). Atara Biotherapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; ImmuCell Corporation trades at 117×. ImmuCell Corporation grew revenue faster over the last twelve months: 8.49% against −96.7%. ImmuCell Corporation has the higher net margin (2.57% vs −269.4%) and the higher return on invested capital (7.84% vs 0.00%). Across the 16 metrics below, ImmuCell Corporation leads on 11 and Atara Biotherapeutics, Inc. on 5.
Valuation
Profitability
| Metric | ATRA | ICCC | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.38% | 40.32% | 65.16% |
| Operating margin | (229.67%) | 12.60% | 0.00% |
| Net margin | (269.42%) | 2.57% | 0.00% |
| Free cash flow margin | (353.49%) | 13.79% | 0.00% |
| Return on equity | 46.33% | 2.57% | (57.72%) |
| Return on assets | (57.62%) | 1.69% | (49.22%) |
| Return on invested capital | 0.00% | 7.84% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack